CYP2C9, CYP4F2, VKORC1 Gene Polymorphism in Buryat Population

被引:1
|
作者
Sambyalova, A. Yu. [1 ]
Bairova, T. A. [1 ]
Belyaeva, E. V. [1 ]
Ershova, O. A. [1 ]
Sargaeva, D. S. [2 ]
Kolesnikov, S. I. [1 ,3 ]
机构
[1] Sci Ctr Family Hlth & Human Reprod Problems, Irkutsk 664003, Russia
[2] Semashko Republican lin Hosp, Ulan Ude 670031, Russia
[3] Moscow MV Lomonosov State Univ, Moscow 119234, Russia
关键词
Buryat population; polymorphism; VKORC1; WARFARIN DOSAGE; VARIANTS; REQUIREMENTS; VARIABILITY; HAPLOTYPES; RS2108622; FREQUENCY; ALLELES; ROMA;
D O I
10.1134/S1022795420120121
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The allele and genotype frequency distribution at polymorphic loci rs1799853 (430C>T) and rs1057910 (A1075C) of the CYP2C9 gene, rs2108622 (1347C>T) of the CYP4F2 gene, and rs9923231 (1639G>A) of the VKORC1 gene in the Buryat population was examined. The study involved 197 volunteers living in the Republic of Buryatia: 124 woman and 73 men, average age of 57.51 +/- 10.88 years. Genetic typing of DNA samples was performed by polymerase chain reaction (RT-PCR). The frequency of the minor alleles *2 and *3 of the CYP2C9 gene was 2.03 and 3.05%, respectively. The frequency of the allele T of the CYP4F2 gene was 31.22%; the frequency of the allele A of the VKORC1 gene was 85.28%. The obtained results could be used in the prognosis of pharmacotherapy of warfarin in the population Buryat population.
引用
收藏
页码:1496 / 1503
页数:8
相关论文
共 50 条
  • [21] Effect of VKORC1, CYP2C9 and CYP4F2 genetic variants in early outcomes during acenocoumarol treatment
    Jose Cerezo-Manchado, Juan
    Roldan, Vanessa
    Rosafalco, Mario
    Isabel Anton, Ana
    Belen Arroyo, Ana
    Garcia-Barbera, Nuria
    Belen Martinez, Ana
    Padilla, Jose
    Corral, Javier
    Vicente, Vicente
    Gonzalez-Conejero, Rocio
    PHARMACOGENOMICS, 2014, 15 (07) : 987 - 996
  • [22] Impact of genetic factors (VKORC1, CYP2C9, CYP4F2 and EPHX1) on the anticoagulation response to fluindione
    Lacut, Karine
    Ayme-Dietrich, Estelle
    Gourhant, Lenaick
    Poulhazan, Elise
    Andro, Marion
    Becquemont, Laurent
    Mottier, Dominique
    Le Gal, Gregoire
    Verstuyft, Celine
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (03) : 428 - 436
  • [23] The effect of polymorphisms in CYP2C9, CYP4F2, EPHX1 and VKORC1 on warfarin dose in Turkish patients
    Ozer, Mahmut
    Demirci, Yeliz
    Sarikaya, Sabit
    Karalti, Iskender
    Kaspar, Cigdem
    Hizel, Candan
    Alpan, Serdar
    Genc, Ece
    CURRENT OPINION IN BIOTECHNOLOGY, 2011, 22 : S125 - S125
  • [24] Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population
    Rusdiana, T.
    Araki, T.
    Nakamura, T.
    Subarnas, A.
    Yamamoto, K.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (03) : 395 - 405
  • [25] Polymorphism of the CYP2C9 and VKORC1 genes: a comment RESPONSE
    Colet, Christiane de Fatima
    JORNAL VASCULAR BRASILEIRO, 2021, 20
  • [26] Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population
    T. Rusdiana
    T. Araki
    T. Nakamura
    A. Subarnas
    K. Yamamoto
    European Journal of Clinical Pharmacology, 2013, 69 : 395 - 405
  • [27] Influence of CYP2C9, VKORC1, and CYP4F2 polymorphisms on the pharmacodynamic parameters of warfarin: a cross-sectional study
    Sridharan, Kannan
    Al Banna, Rashed
    Malalla, Zainab
    Husain, Aysha
    Sater, Mai
    Jassim, Ghufran
    Otoom, Sameer
    PHARMACOLOGICAL REPORTS, 2021, 73 (05) : 1405 - 1417
  • [28] PHARMACOGENOMIC VARIANTS OF CYP2C9, CYP4F2 AND VKORC1 AND ITS RELATION TO WARFARIN RESPONSE IN NATIVE OMANI PATIENTS
    Pathare, A.
    AlZadjali, S.
    Misquith, R.
    Gravell, D.
    Al Falahi, K.
    Al-Haddabi, H.
    Krishnamoorthy, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 668 - 668
  • [29] Influence of CYP2C9, VKORC1, and CYP4F2 polymorphisms on the pharmacodynamic parameters of warfarin: a cross-sectional study
    Kannan Sridharan
    Rashed Al Banna
    Zainab Malalla
    Aysha Husain
    Mai Sater
    Ghufran Jassim
    Sameer Otoom
    Pharmacological Reports, 2021, 73 : 1405 - 1417
  • [30] Study of VKORC1, CYP2C9, and CYP4F2 polymorphisms and their association with warfarin dose requirements in Egyptian patients.
    Shahin, Mohamed H.
    Khalifa, Sherief I.
    Sallam, Tarif H.
    Hammad, Lamiaa N.
    El Shafey, Mostafa
    Ali, Shawky S.
    Mohamed, Mohamed-Eslam F.
    Langaee, Taimour
    Johnson, Julie A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1065 - 1065